Hook & Thesis
Eldorado Gold (EGO) is set up for a clear rerating catalyst: a combination with Foran Mining that creates a materially larger, diversified Canadian-focused precious and base metals company with two fully financed development projects moving toward production in 2026. Management and a major shareholder (Fairfax) are aligned, project execution resources have been added via a delivery alliance, and the pro-forma numbers imply a very low EBITDA multiple versus current market capitalization.
That matters because the market is still pricing EGO like a single-asset junior rather than a multi-asset producer with a projected $2.1 billion in EBITDA and $1.5 billion in free cash flow in 2027 for the combined entity. At today’s price ($35.805), pro-forma valuation versus the 2027 outlook implies an attractive multiple and a short runway to meaningful cash generation — a setup I view as actionable with clear entry, stop and target levels.
Business summary - What Eldorado does and why investors should care
Eldorado Gold is an international gold miner operating in Turkey, Canada and Greece. The company is executing a near-term growth story: two development projects included in the Foran combination are expected to advance to production in mid-2026 and Q4 2026. Management has also announced leadership upgrades and a strategic alliance with a specialist engineering and construction partner to de-risk project delivery.
Why the market should care: the transaction and project pipeline are expected to transform Eldorado into a higher-EBITDA, cash-generative company. The combined entity is projected to generate approximately $2.1 billion in EBITDA and about $1.5 billion in free cash flow in 2027, numbers that materially change the company’s earnings and cash flow profile compared to stand-alone expectations.
Hard numbers investors should focus on
- Current share price: $35.805.
- Market capitalization: approximately $7.1 billion (snapshot market cap ~ $7.12B).
- Enterprise value reported: ~ $6.87 billion.
- Shares outstanding ~ 198.7 million, float ~ 197.5 million.
- 52-week range: $15.30 - $51.16.
- Pro-forma 2027 outlook for the combined company: $2.1 billion EBITDA and $1.5 billion free cash flow (company guidance tied to the transaction).
- Balance sheet indicators: reported debt/equity ~ 0.17, which suggests modest leverage relative to the projected cash flow ramp.
- Technicals: 10-day SMA ~$33.75, 50-day SMA ~$40.87; RSI ~ 46.6 - the stock is trading below the 50-day but above the 10-day, showing a potential base with room to run if catalysts land.
Valuation framing - Why the stock looks cheap on a pro-forma basis
Take the company’s market cap (~$7.1B) and compare it to the expected 2027 EBITDA for the combined entity: $2.1B. On a simple market-cap-to-EBITDA comparison the implied multiple is in the low single digits (roughly ~3.4x). Even using enterprise value (~$6.87B) versus $2.1B yields an EV/EBITDA of ~3.3x on a pro-forma basis. That is materially lower than where most mid-tier producers trade on a normalized basis.
Note: the current market pricing still reflects execution risk, permitting uncertainty in some jurisdictions and the fact that the pro-forma numbers are forward-looking. If Eldorado executes on the two development projects and the combined company converts the 2027 cash flow profile into reality, the rerating potential is significant — re-rating to a more normal mid-teens EBITDA multiple for a producing peer group would imply very meaningful upside.
Catalysts (what to watch)
- 4/07/2026 - Shareholder vote on the Eldorado-Foran arrangement. A clean vote unlocks the pro-forma scale and associated financing / project timing.
- Mid-2026 and Q4-2026 - Targeted production ramp of two development projects cited in management guidance; first ore and commissioning milestones will be market-moving.
- Project delivery alliance updates - progress updates and cost-control metrics from the G Mining Services alliance will be key; evidence of on-time, on-budget delivery reduces execution risk substantially.
- Leadership transition updates - clarity on the CEO succession plan (management indicated a change in Q3 2026) and continuity around project execution will affect investor confidence.
Trade plan (actionable)
Here is a clear, executable trade that balances upside from a pro-forma rerating with disciplined risk control.
| Action | Price | Horizon |
|---|---|---|
| Entry | $36.00 | Primary: long term (180 trading days). Mid-term checkpoint: 45 trading days. |
| Stop loss | $29.00 | |
| Target | $52.00 |
Rationale: Entry at $36 is at/near the current market price and offers a reasonable risk/reward if the Foran vote passes and the development projects hit their delivery milestones. The stop at $29 protects capital if the combined entity faces setbacks or if the market re-prices risk aggressively. The target of $52 is anchored to the 52-week high and reflects a conservative rerating toward a mid-tier producer multiple; if earnings and cash flow land as projected, upside could extend beyond $52, but this target balances ambition and realism.
Timeframes: use a mid-term checkpoint at 45 trading days to evaluate early post-close trading and initial project updates. Keep the full position timeframe to 180 trading days to capture production starts and the 2027 cash flow narrative.
Key supporting points for the trade
- Pro-forma scale: the combination creates a business with meaningful EBITDA and FCF potential ($2.1B EBITDA / $1.5B FCF in 2027).
- Capital and governance support: Fairfax has entered a voting support agreement, and ISS recommended Foran shareholders vote in favor — those endorsements materially lower the execution risk on the deal closing.
- Project delivery focus: the MOU with a specialist engineering and construction partner is a pragmatic step to reduce cost and schedule overrun risk.
- Relatively clean balance sheet: reported debt/equity ~0.17 signals capacity to fund growth without extreme leverage.
Risks and counterarguments
Below are the main risks to the thesis and a counterargument investors should monitor.
- Execution risk on development projects - Mining projects commonly face delays and cost overruns. If commissioning is delayed beyond the stated mid-2026 / Q4-2026 windows, the projected 2027 cash flows will be pushed out, compressing valuation.
- Integration and transaction risk - The Foran arrangement requires shareholder approvals and a clean integration. Any hiccup in votes, regulatory scrutiny, or unexpected liabilities uncovered during closing could stall the rerating.
- Commodity price sensitivity - Gold and copper price swings materially affect EBITDA and free cash flow. A sustained drop in metals prices would reduce upside and could invalidate the multiple expansion thesis.
- Political and permitting risk - Operating jurisdictions include Turkey and Greece where permitting, social license, or political decisions can affect timelines and costs.
- Market skepticism / sentiment risk (counterargument) - The market has historically demanded proof — not promises — on large projects. If investors remain skeptical about the company’s ability to convert guidance into realized cash flow, the stock may remain range-bound even after transaction close. This is a plausible outcome and a reason to use the mid-term (45 trading days) checkpoint to reassess conviction.
What would change my mind
I will downgrade this trade if any of the following occur: a material negative vote outcome or regulatory obstacle to the Foran combination; clearly visible cost overruns or major schedule slippage on either development project; a sustained commodity price decline that meaningfully reduces the 2027 EBITDA/F CF outlook; or any material deterioration in the balance sheet (e.g., large surprise debt or contingent liabilities). Conversely, beat-or-better-than-guided production starts, confirmed capex discipline and early FCF generation would push me to add to the position and extend targets higher.
Conclusion
Eldorado Gold is an actionable long at current levels based on the pro-forma valuation implied by 2027 guidance. The combination with Foran, Fairfax support, new project delivery arrangements, and two near-term production catalysts create a time-limited asymmetric opportunity. Use disciplined sizing, a $29 stop and a $52 target, watch the 4/07/2026 vote and the mid-2026 / Q4-2026 production milestones, and re-evaluate at the 45 trading-day checkpoint.
Trade setup: Buy $36.00, stop $29.00, target $52.00. Primary horizon: long term (180 trading days) with a mid-term checkpoint at 45 trading days.